Therapeutic considerations: Rating scales

Richard Rudick, Brian G Weinshenker, Gary Cutter

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

I. INTRODUCTION Quantifying the clinical impact of multiple sclerosis (MS) is necessary for a number of reasons. Clinical assessment tools are needed for patient care. If not for clinical outcome assessments, how would a neurologist determine disease severity or the effect of treatment? Clinical assessment tools are also indispensable for judging experimental therapies. If not for clinical assessment tools, how would investigators measure the effectiveness of an intervention?.

Original languageEnglish (US)
Title of host publicationHandbook of Multiple Sclerosis, Third Edition
PublisherCRC Press
Pages465-491
Number of pages27
ISBN (Electronic)9780824741846
ISBN (Print)9780824704858
StatePublished - Jan 1 2001

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Therapeutic considerations: Rating scales'. Together they form a unique fingerprint.

  • Cite this

    Rudick, R., Weinshenker, B. G., & Cutter, G. (2001). Therapeutic considerations: Rating scales. In Handbook of Multiple Sclerosis, Third Edition (pp. 465-491). CRC Press.